Malaria news, resources and funding for global health researchers
Malaria is a mosquito-borne disease causing fever, chills and flu-like illness that can be fatal. Despite an increased focus on malaria, it still claims hundreds of thousands of lives each year, most of them children in Africa. Poor quality antimalarial drugs, which lead to
drug resistance and inadequate treatment, are also a growing concern, posing an urgent threat to vulnerable populations.
Fogarty has supported a wide range of efforts to combat malaria, including the Multilateral Initiative on Malaria, an international effort to identify and address malaria research priorities.
Ecology and Evolution of Infectious Diseases, a joint NIH - National Science Foundation (NSF) initiative, funds malaria-related projects in Kenya, Papua New Guinea, Belize and more. Through the
Global Infectious Disease program, Fogarty has supported research training efforts that advance scientific discoveries, while developing local malaria research capacity in places where it's needed most.
Fogarty's
epidemiology division studies malaria transmission patterns, drug resistance and other related topics, modeling malaria's prevalence and impact.
Recent News
-
More malaria cases and deaths in 2020 linked to COVID-19 disruptions
WHO news release, December 6, 2021 -
WHO recommends groundbreaking malaria vaccine for children at risk
WHO news release, October 6, 2021
-
U.S. President’s Malaria Initiative (PMI) has announced its new five-year strategy to end malaria faster
PMI news release, October 6, 2021
- WHO issues new guidance for research on genetically modified mosquitoes to fight malaria and other vector-borne diseases
WHO news release, May 19, 2021 -
NIH researchers discover new set of channels connecting malaria parasite and blood cells
Discovery provides new target for anti-malaria treatments
NICHD/NIH news, July 30, 2020 -
Foundation for the NIH launches GeneConvene Global Collaborative
FNIH news, July 23, 2020
-
Assessment of long-term health effects of antimalarial drugs when used for prophylaxis
National Academies of Sciences, Engineering and Medicine, 2020 -
NIH study supports new approach for treating cerebral malaria
NINDS/NIH news, February 18, 2020 -
First human trial of monoclonal antibody to prevent malaria opens
NIH trial will test NIAID-developed antibody
NIAID/NIH news, January 27, 2020
Related Fogarty News and Information
- Spatio-temporal modelling of malaria mortality in India from 2004 to 2013 from the Million Death Study
co-authored by Fogarty grantee Dr. Prabhat Jha
Malaria Journal, March 17, 2022
-
Blood-feeding patterns of Anopheles vectors of human malaria in Malawi: implications for malaria transmission and effectiveness of LLIN interventions
co-authored by Fogarty grantees Dr. Don Mathanga and Dr. Miriam Laufer
Malaria Journal, March 3, 2022
-
Scientists in Tanzania show bacterial zoonoses, not malaria, often the cause of febrile diseases
Nov / Dec 2020
Global Health Matters -
Profile: Fogarty Fellow Jillian Armstrong studies novel malaria detection device in Cameroon
Jan / Feb 2020
Global Health Matters -
Poor quality drugs for treating malaria, pneumonia, hypertension and other diseases pose “public health emergency,” study says
Mar / Apr 2019
Global Health Matters -
Scientists in Tanzania show bacterial zoonoses, not malaria, often the cause of febrile diseases
Nov / Dec 2020
Global Health Matters -
Profile: Fogarty Fellow Jillian Armstrong studies novel malaria detection device in Cameroon
Jan / Feb 2020
Global Health Matters -
Poor quality drugs for treating malaria, pneumonia, hypertension and other diseases pose “public health emergency,” study says
Mar / Apr 2019
Global Health Matters -
Chinese researchers discovered effectiveness of artemisinin against malaria
Sep / Oct 2015
Global Health Matters -
Global pandemic of fake medicines poses urgent risk, scientists say
May / Jun 2015
Global Health Matters -
Q and A with world-renowned malaria research expert Dr Chris Plowe
May / Jun 2015
Global Health Matters - Fogarty Global Infectious Diseases grantee news:
An American doctor may have solved a deadly mystery about malaria
PRI's
The World, May 5, 2015
-
Fogarty funding spurs global health innovations, including a project to develop low-cost malaria diagnostics in Zambia
Nov / Dec 2013
Global Health Matters -
Fogarty funds ecology, genetics studies of malaria in Ghana
Nov / Dec 2013
Global Health Matters -
Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications
Meeting report on Fogarty and NIAID conference on artemisinin-resistant malaria
American Society of Tropical Medicine and Hygiene, August 2012 -
Fogarty study shows poor quality and fake malaria drugs pose threat
May / Jun 2012
Global Health Matters -
Call to action on drug-resistant malaria
Fogarty/NIH News, September 22, 2011
NIH News and Resources
- National Institute of Allergy and Infectious Diseases (NIAID) Malaria Topic Page
- National Library of Medicine (NLM)'s MedlinePlus on Malaria
Other US Government Resources
Other Online Resources
Updated June 6, 2022